Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology
Sector: Health Care

Stock price data as of 09/25/2020

Closing price: 62.25

Support price level:	N/A
Resistance price level:	$69.05
Relative strength index (14-day RSI)	30.5
Beta	0.07

GILD is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
The price of this low-beta stock is expected to increase by 0.07% for every 1% increase in the S&P-500.
Volatility is forecast to rise over the next month.
Price broke below prior support level - a short-term bearish signal.

Low	High	Price as % of Range
$61.62	$84.00	3.3%

200 day	50 day	20 day	10 day
$71.45	$68.21	$64.90	$64.35

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
28.9%	23.4%	22.7%	28.0%

There is an estimated 5% probability that the stock price of Gilead Sciences Inc will fall by more than: